0001104659-20-094439.txt : 20200813 0001104659-20-094439.hdr.sgml : 20200813 20200813100239 ACCESSION NUMBER: 0001104659-20-094439 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200813 DATE AS OF CHANGE: 20200813 EFFECTIVENESS DATE: 20200813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Foresite Capital Management II, LLC CENTRAL INDEX KEY: 0001594912 IRS NUMBER: 464028844 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16497 FILM NUMBER: 201097689 BUSINESS ADDRESS: STREET 1: 600 MONTGOMERY STREET STREET 2: SUITE 4500 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-877-4887 MAIL ADDRESS: STREET 1: 600 MONTGOMERY STREET STREET 2: SUITE 4500 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001594912 XXXXXXXX 06-30-2020 06-30-2020 false Foresite Capital Management II, LLC

600 Montgomery Street Suite 4500 San Francisco CA 94111

13F HOLDINGS REPORT 028-16497 N James B. Tananbaum 415-877-4887 /s/ James B. Tananbaum San Francisco CA 08-13-2020 0 3 508684 INFORMATION TABLE 2 infotable.xml 10x Genomics, Inc. CLASS A COMMON 88025U109 491520 5503528 SH SOLE 5503528 0 0 Acceleron Pharma Inc. COM 00434H108 3314 34784 SH SOLE 34784 0 0 Epizyme, Inc. COM 29428V104 13850 862402 SH SOLE 862402 0 0